Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan.

Breast Cancer (Dove Med Press) · 2026 · PMC13242758 · PMID 42261320

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

<NT$18,000: aHR 0.670, 95% CI 0.483–1.001; P = 0.051) showed a trend towards better survival, though not reaching statistical significance for the highest category in this model.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.